Send to

Choose Destination
Indian Dermatol Online J. 2014 Jan;5(1):1-3. doi: 10.4103/2229-5178.126017.

Sorafenib and sunitinib: A dermatologist's perspective.

Author information

Department of Dermatology, Command Hospital, Pune, India.


Sorafenib and sunitinib are inhibitors of tumor angiogenesis have recently generated curiosity regarding its role in cutaneous toxicities, which has severely affected the daily activities resulting in interruption or dose modification of therapy in renal cell carcinoma and hepatocellular carcinomas. We discuss the pathophysiology, adverse cutaneous effects and their grading, potential high risk factors, role of gene polymorphism, critical period of hand-foot skin reaction development and their management.


Burgdorf reaction; hand-foot skin reaction; palmar-plantar erythrodysesthesia

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center